Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes. - Wikidata - wikimedia - TriplyDB

Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.

Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.

http://www.wikidata.org/entity/Q34103739

about

Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.Differential Expression Levels of Integrin α6 Enable the Selective Identification and Isolation of Atrial and Ventricular Cardiomyocytes Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density Derivation of cardiac progenitor cells from embryonic stem cells A device for rapid and quantitative measurement of cardiac myocyte contractility Prospects for In Vitro Myofilament Maturation in Stem Cell-Derived Cardiac Myocytes.Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease.Non-genetic Purification of Ventricular Cardiomyocytes from Differentiating Embryonic Stem Cells through Molecular Beacons Targeting IRX-4.Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.Pluripotent stem cells as a platform for cardiac arrhythmia drug screening Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.Technical approaches to induce selective cell death of pluripotent stem cells.Concise Review: Criteria for Chamber-Specific Categorization of Human Cardiac Myocytes Derived from Pluripotent Stem Cells.Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.Engineering human ventricular heart muscles based on a highly efficient system for purification of human pluripotent stem cell-derived ventricular cardiomyocytes.Maturation of pluripotent stem cell derived cardiomyocytes: The new challenge.hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Platform for Testing For Drug Cardiotoxicity.Developmental changes in electrophysiological characteristics of human-induced pluripotent stem cell-derived cardiomyocytes.Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells.Differences in Contractile Function of Myofibrils within Human Embryonic Stem Cell-Derived Cardiomyocytes vs. Adult Ventricular Myofibrils Are Related to Distinct Sarcomeric Protein Isoforms.An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes.Genome Editing Redefines Precision Medicine in the Cardiovascular Field.Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem Cells

P2860

Q26798131-4564B70F-7C7C-4243-BDA6-3841926EF929 Q26799437-CB2D66A8-CCE7-4176-A450-5D3640698BFB Q27329596-DD928F5A-F56F-4C00-9A09-7C9CC0A97913 Q27339919-E7760772-50D2-4C5D-BD21-1F9BF3EF57E9 Q33704567-139A3132-1ABC-423A-9D8F-CE5DB5E33345 Q33821060-CA26C37B-0F37-430D-AB74-188867CD62A8 Q34862866-D0008C23-0AA1-4849-9909-F8E48B0BCAF9 Q35161897-AB2561DB-7470-4927-811D-3D1EF9263966 Q35224954-C9E1667C-B825-4205-819B-4106F28E624C Q35724421-3CA41A24-22A3-4A64-8CFB-F23FF38642D6 Q35832615-701FE00C-48CD-4B4B-BA6A-42BCDB120FCB Q36379875-57BA449B-0DFC-4780-93B9-B8DF7FB56838 Q36801655-61CDFE9B-EB92-4005-B689-70F28EFAD9A3 Q38235190-8B3425D8-69F7-4913-852E-ABC5E64B8233 Q38583455-9226AEA7-6620-488B-930D-3DF80D9AC792 Q38657334-233547DF-1665-445C-B4EF-099CAA17D68F Q38819976-226BA165-6A9C-45A5-AED0-1DA945368797 Q38910418-D3129170-4963-42B2-BD94-17A862AD472A Q39155502-79A6E625-DBE2-4CFB-9311-A0490F147F02 Q39347586-456B383A-7664-4EDE-A606-0429FACAB678 Q40381516-D41BDC4C-3462-4DFD-922E-245F6006CA4B Q41664792-F512A99A-DA49-4B29-B544-97D8A5408CB9 Q41997367-02578418-A4B5-46E5-97C0-7DBF6342C3A1 Q42378627-A23F2429-6F06-46A1-AF08-FF66229B36FA Q42645439-6D4C458D-269C-4E35-A6E3-79FAB1698890 Q46425614-8A06A5E1-1E9E-4F80-B55F-36630D6B510F Q46801702-5F197D81-98EC-4950-9333-C440E955A8FE Q46854596-7E8F43D9-F0A4-48C0-BB12-AB162ADD2337 Q48332216-80DDE4CA-0C1D-4A0B-AB68-DA651BDB2E5B Q49185907-F2BF31DB-C790-4250-8B8A-751AFD8EC86E Q49824944-7E0C9B6F-4A42-462E-8E27-590F4555B77E Q55012020-3B1ECC98-6B48-40FE-8EE9-C73D351B0ECE Q58772675-E4DBCF1E-0929-4FD3-85F3-BDA52481E04F

P2860

Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.

http://www.wikidata.org/entity/Q34103739

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@ast

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@en

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@nl

type

label

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@ast

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@en

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@nl

prefLabel

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@ast

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@en

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@nl

P1433

Q34103739-9FFA7A74-40B6-46C1-AABA-F15529205965

P1476

Q34103739-97FE7634-A6B3-45CE-A83E-6ED80C785AC7

P2093

Q34103739-1C81EE9A-2165-48A8-8C4C-76C179F4E787

Q34103739-2994002C-662F-473B-A9E0-04C106DAAF7D

Q34103739-44BB70EB-2932-4D11-B160-4BA9E380E2A9

Q34103739-8E193808-6972-4CE4-9223-9031D1DE3161

Q34103739-96C3033B-6613-4C3C-B45B-68957047E353

Q34103739-9D6A5DE2-5750-4801-81EB-110EDDFF43E2

Q34103739-A669AE48-A29C-4470-80BB-804918551C03

Q34103739-AD63F3BA-711A-404D-9F03-ACE4037CA56C

Q34103739-F6B28748-C110-4134-9D28-C3AC492B45BE

P2860

Q34103739-02D575A5-4668-4CD3-90B4-F4A28E957583

Q34103739-0CF45E25-768C-47BD-A397-68431C61C453

Q34103739-0FB1DB8C-CCCB-4362-9FF0-0107FC1D3017

Q34103739-185F7781-EFEA-4F20-82EF-9D9761842711

Q34103739-25D033B6-ED5A-47FF-BE4C-0C7A2E1F60A4

Q34103739-36E448DF-CE9B-492C-AF08-84C527F4D23D

Q34103739-3DD13B36-8624-4120-A842-EEE65E33DB50

Q34103739-3E07E660-C536-41B2-B51C-FB22003C8048

Q34103739-42A81D2E-1BC5-49E1-9F12-31E834F35C8F

Q34103739-4E4B55D1-BCBE-47DF-99C0-FC2A88566020

P304

Q34103739-8F7B5074-06E1-4CF7-B4AA-527DE974ABF3

P31

Q34103739-3A06EB04-2C2A-4B63-9769-7540F6F6F32B

P356

Q34103739-943B3E36-8B63-4755-85D6-1C6C663E1C7E

P433

Q34103739-B59273D0-B818-4C19-BF27-E13CE15C6E24

P478

Q34103739-A6BDC7B2-D788-4FD6-A20A-B23FFC507FB5

P50

Q34103739-1EE95B98-9A18-465F-8A91-0B2FCF4F0727

Q34103739-2FBC1737-89B7-49D7-B010-87DADDC33E78

Q34103739-61DC638B-A629-4819-BEAA-E29E206B64BA

Q34103739-6B04ABD7-262F-4120-902B-D1A9D737A261

Q34103739-7C036BB5-C2DA-4849-9DC5-7636C3F47AEF

P577

Q34103739-29B201E6-C591-4EDF-BE67-0C473B7191BB

P5875

Q34103739-934EEE23-932D-46C9-8F87-498FE47BBB72

P698

Q34103739-6CD8CCFC-E458-459F-9510-D0F3AD4E947F

P932

Q34103739-B7B7D995-970E-4157-A37E-A5545CD16D6F

P356

J.SCR.2013.09.003

P1433

Stem Cell Research

P1476

Myosin light chain 2-based sel ...... ventricular cardiac myocytes.

@en

P2093

Bin Hu

http://www.w3.org/2001/XMLSchema#string

Daniela Ponce-Balbuena

http://www.w3.org/2001/XMLSchema#string

Eric J Devaney

http://www.w3.org/2001/XMLSchema#string

Guadalupe Guerrero-Serna

http://www.w3.org/2001/XMLSchema#string

Karen L Vikstrom

http://www.w3.org/2001/XMLSchema#string

Lakshmi V Mundada

http://www.w3.org/2001/XMLSchema#string

Michelle F Sener

http://www.w3.org/2001/XMLSchema#string

Rafael J Ramirez

http://www.w3.org/2001/XMLSchema#string

Todd J Herron

http://www.w3.org/2001/XMLSchema#string

P2860

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression

Differential regulation of the atrial isoforms of the myosin light chains during striated muscle development

Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube

CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression

HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments

Human induced pluripotent stem cells free of vector and transgene sequences

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

P304

1335-1347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCR.2013.09.003

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

B Cicero Willis

P577

2013-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257462869

http://www.w3.org/2001/XMLSchema#string

P698

24095945

http://www.w3.org/2001/XMLSchema#string

P932

4148042

http://www.w3.org/2001/XMLSchema#string